Targeted Delivery of Plasminogen Activators for Thrombolytic Therapy: An Integrative Evaluation

In thrombolytic therapy, plasminogen activators (PAs) are still the only group of drug approved to induce thrombolysis, and therefore, critical for treatment of arterial thromboembolism, such as stroke, in the acute phase. Functionalized nanocomposites have attracted great attention in achieving tar...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Yunn-Hwa Ma, Chih-Hsin Liu, Yueh Liang, Jyh-Ping Chen, Tony Wu
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	MDPI AG 2019-09-01
Schriftenreihe:	Molecules
Schlagworte:	plasminogen activators nanoparticles drug delivery thrombolysis
Online-Zugang:	https://www.mdpi.com/1420-3049/24/18/3407
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!